Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

857 Development of an mRNA cancer vaccine platform enabling flexible antigen exchange and dendritic cell selected delivery to overcome immune tolerance

  1. 11Samyang Biopharmaceuticals Corp., Pangyo, Republic of Korea
  2. 22Samyang Biopharamaceuticals Inc, Seongnamsi, Republic of Korea
  3. 3Samyang Biopharmaceuticals Corporation, Gyeonggi-do, Korea, Republic of

Related

  1. Dendritic computation for abstract rule-based flexible decision-making
    Yuan Zhang, Yanhe Liu, Yu Hu +11
    SciencePeer-reviewedLicence not statedFull text18 citedNeuroscienceOpenAlex
  2. A Double-Edged Sword: The Dichotomous Roles of Dendritic Cell Subsets in Shaping CD8+ T Cell Immunity and Tolerance Within the Tumor Microenvironment
    Guoyao Gao, Ke Chen
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  3. Same Factor, Different Branches: Context-Dependent Control of Dendritic Development by Lhx2
    Lauren Campbell, Ana Dorrego-Rivas
    eneuroPeer-reviewedCC BY-NC-SA 4.0Full textNeuroscienceCrossref
  4. Mathematical model for visual cortical development based on molecular mechanisms underlying the generation and elimination of dendritic spines
    S. Tanaka, M. Miyashita
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  5. BRIDGE: A broad-host platform for interkingdom DNA delivery enabling the genetic domestication of phylogenetically diverse yeasts
    R. Swidah, R. Cochrane, F. Valle +1
    bioRxivPreprintCC BYFull textSystems & synthetic biologybioRxiv
BibTeX
@article{kim2026development,
  title = {{857 Development of an mRNA cancer vaccine platform enabling flexible antigen exchange and dendritic cell selected delivery to overcome immune tolerance}},
  author = {So-Young Kim and Helen Cho and Sojin Lee},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0857},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0857},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 857 Development of an mRNA cancer vaccine platform enabling flexible antigen exchange and dendritic cell selected delivery to overcome immune tolerance
AU  - So-Young Kim
AU  - Helen Cho
AU  - Sojin Lee
PY  - 2026
DA  - 2026/11/08
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0857
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0857
SN  - 2051-1426
ER  -